Filter
2018
Filtered Results: 2018
Text search:
pharmaceutical
management
Featured
Recommendations
195
New Publications
572
Language
Document type
No document type
1054
Studies & Reports
358
Guidelines
335
Manuals
92
Strategic & Response Plan
92
Fact sheets
32
Training Material
24
Situation Updates
13
Resource Platforms
11
Infographics
4
Brochures
2
Online Courses
1
Countries / Regions
Kenya
88
Ethiopia
83
India
81
Global
73
South Africa
53
Nigeria
46
Western and Central Europe
46
Liberia
40
Sierra Leone
38
Uganda
38
Ghana
31
Nepal
30
Rwanda
30
Tanzania
29
Namibia
29
Zambia
28
Malawi
26
Bangladesh
25
Africa
25
Ukraine
22
Latin America and the Carribbean
21
Philippines
20
Indonesia
18
Syria
17
Eastern Europe
17
Lesotho
16
Zimbabwe
15
Cambodia
15
Eswatini/ Swaziland
13
Myanmar / Burma
13
South–East Asia Region
13
Congo, Democratic Republic of
12
Botswana
11
West and Central Africa
11
Germany
9
Eastern Europe and Central Asia
9
Cameroon
8
South Sudan
8
East and Southern Africa
8
Asia
8
Russia
8
Guinea
7
Senegal
7
Brazil
7
Burkina Faso
6
Haiti
6
Thailand
6
Middle East and North Africa
5
Western Pacific Region
5
Pakistan
4
Mozambique
4
Papua New Guinea
4
Benin
4
Albania
4
Laos
4
Vietnam
4
Mali
3
USA
3
Jordan
3
Afghanistan
3
Egypt
3
China
3
Sudan
3
North Macedonia
3
Chile
3
Fiji
3
United Kingdom
3
Iraq
2
Lebanon
2
Central African Republic
2
Serbia
2
Yemen
2
Southern Africa
2
Tajikistan
2
Lithuania
2
Moldova
2
Kyrgyzstan
2
Georgia
2
North America
2
Jamaica
2
Saudi Arabia
1
Niger
1
Somalia
1
Chad
1
Argentina
1
Peru
1
Bolivia
1
Libya
1
Angola
1
Sri Lanka
1
Bhutan
1
Venezuela
1
Palestine
1
Armenia
1
Timor Leste/ East Timor
1
Bulgaria
1
Romania
1
Iran
1
Uzbekistan
1
Australia
1
Kazakhstan
1
Gabon
1
Turkmenistan
1
Japan
1
Denmark
1
Belgium
1
France
1
Maldives
1
Portugal
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
857
Clinical Guidelines
136
Public Health
108
Key Resources
77
Women & Child Health
50
Pharmacy & Technologies
32
Capacity Building
15
Annual Report MEDBOX
2
Toolboxes
Pharmacy
202
AMR
191
COVID-19
149
Mental Health
106
TB
101
HIV
100
Rapid Response
61
NCDs
47
Planetary Health
46
Caregiver
42
NTDs
41
Ebola
35
Conflict
35
Global Health Education
33
Health Financing Toolbox
21
Specific Hazards
14
Disability
11
Polio
11
Natural Hazards
11
Refugee
11
Social Ethics
3
Cholera
2
Health Financing
2
South Sudan
1
Zika
1
MICROBIAL DRUG RESISTANCEVolume 24, Number 5, 2018ªMary Ann Liebert, Inc.DOI: 10.1089/mdr.2017.0383
Antibiotic resistance (ABR) is a worldwide publichealth concern, with serious health, economic, and so-cietal repercussions. Its emergence is attributed to the se-lective pressure exerted by antib...
COVID-19 disproportionately affects the poor and vulnerable. Community health workers are poised to play a pivotal role in fighting the pandemic, especially in countries with less resilient health systems. Drawing from practitioner expertise across four WHO regions, this article outlines the targete...
Guidelines for Diagnosing and Managing Disseminated Histoplasmosis among People Living with HIV
recommended
Histoplasmosis is a disease caused by the fungus Histoplasma capsulatum. This disease is highly endemic in some regions of North America, Central America, and South America and is also reported in certain countries of Asia and Africa. It often affects people with impaired immunity, including people ...
As part of our commitment to the fight against NCDs, Nigeria was signatory to the political declaration at the UN General Assembly High Level Meeting on NCDs in September 2011. Thus, the purpose of this document is to develop and ensure the implementation of policies and p...
Overcoming barriers in low- and middle-income countries
For the first time, this year’s report includes information on hepatitis C diagnostics. With a focus on selected countries with diverse HCV epidemics, the report provides updates on the various dimensions of access to HCV diagnostics and ... products, including product pricing, the regulatory environment and patent status, which together shape the national hepatitis response in different settings. It highlights key areas for action by ministries of health and other government decision-makers, pharmaceutical manufacturers and technical partners.
August 2020.
Essential diagnostic products areconsidered an integral part of UHC, they are an indispensable element for delivery ofservices andare also a requirement for qualitycare. Despite this realization, a review of the UHC pilot in September 2019 es...
PHARMA’S RESPONSE TO THE COVID-19 VACCINES CRISIS. Update Feb., 14, 2022. In September 2021, Amnesty International published A Double Dose of Inequality, which assessed the extent to which the pharmaceutical industry was restricting access to Covi...
Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
recommended
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys...
COVID-19 has altered health sector capacity in low-income and middle-income countries (LMICs). Cost data to inform evidence-based priority setting are urgently needed. Consequently, in this paper, we calculate the full economic health sector costs of COVID-19 clinical ... in 79 LMICs under different epidemiological scenarios.
This report started with a simple question—“How can we tell how much funding is devoted to global health programs?”—and ended (more than two years later) with an answer that is far from simple. As those who have tried know well, tracking health-related funding is challenging in any setting, ...
Access to safe blood and blood products is recognized as one of the key requirements for delivery of modern health care in the journey towards health for all. The foundation of safe and sustainable blood supplies depends on the collection of blood from voluntary non-remunerated and low-risk donors. ...
The Infection prevention and control in the context of coronavirus disease 2019 (COVID-19): a living guideline consolidates technical guidance developed and published during the COVID-19 pandemic into evidence-informed recommendations for infection prevention and control (IPC). This living guideline...
The Disaster Recovery Framework (DRF) Guide for the Health Sector provides guidance on how to implement a comprehensive, integrated, and structured approach to disaster recovery. Its overarching goal is to minimize the impact of the disaster on communities and help countries to recover quickly and e...
Chronic kidney disease (CKD) is an important contributor to mortality from noncommunicable diseases. No decrease has been seen for CKD mortality contrary to many other important non-communicable diseases (e.g., cardiovascular disease). The prevalence of CKD and kidney failure are increasing all over...
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys...
The checklist tool described in this handbook is intended for EU/EEA public health authorities who need to assess the capacity for communicable disease prevention and control at migrant reception/detention centres hosting migrants for weeks/months (medium-term) in order to identify gaps and set prio...
An Advocate’s Guide: Strategic Indicators for Universal Access to Sexual and Reproductive Health and Rights
recommended
This guide was prepared to enable advocates to use data
when advocating for universal access to SRHR at the national,
regional and global levels. It is a direct outcome of the Strategic
SRHR Indicators workshop held in Kuala Lumpur, Malaysia on
21-22 August for the project “Strengthening the N...
First published in 2020, this toolkit is intended for clinicians working in acute care, managing adult and paediatric patients with acute respiratory infection, including severe pneumonia, acute respiratory distress syndrome, sepsis and septic shock. The main objective is to provide key tools for us...
The key areas covered are diagnosis, imaging, pathology, surgery, rehabilitation, palliative care and survivorship. It emphasizes a multi-disciplinary team approach which is paramount for quality cancer care. The specific cancers covered are breast, central nervous system, gastroint...
Rabies has an enormous impact on both agriculture and conservation biology, but its greatest burden is undeniably on public health. As such, routine methods for rapid risk assessment after human exposures to rabies as well as applications for laboratory-based surveillance, production of biologicals ...
